Jennifer Boggs

Heading To Clinic, Nereus Adds $18.3M To Series D

March 7, 2006

By Jennifer Boggs

ARCA Gets $15M Series A To Support Bucindolol NDA

March 6, 2006

By Jennifer Boggs

ARCA Gets $15M Series A To Support Bucindolol NDA

March 6, 2006

By Jennifer Boggs

ImQuest Gains Dual-Mechanism HIV Compounds From Samjin

March 1, 2006

By Jennifer Boggs

Though it’s only a month into a strategic drug development agreement between ImQuest Pharmaceuticals Inc. and Samjin Pharmaceutical Co. Ltd., the alliance already has yielded its first licensing deal. (BioWorld Today)

ImQuest Gains Dual-Mechanism HIV Compounds From Samjin

March 1, 2006

By Jennifer Boggs

Though it’s only a month into a strategic drug development agreement between ImQuest Pharmaceuticals Inc. and Samjin Pharmaceutical Co. Ltd., the alliance already has yielded its first licensing deal. (BioWorld Today)

Novavax Adding $20M To Support Flu Vaccine Work

Feb. 28, 2006

By Jennifer Boggs

OrthoLogic Broadens Pipeline With AzERx’s ICARM Platform

Feb. 27, 2006

By Jennifer Boggs

Celtic Pharma’s New Acquisition Adds Drug Delivery Technology

Feb. 24, 2006

By Jennifer Boggs

Global private equity firm Celtic Pharmaceutical Holdings LP gained access to a targeted drug delivery technology from IDEA AG, as well as clinical and preclinical products in pain and inflammation, dermatitis and psoriasis. (BioWorld Today)

Celtic Pharma’s New Acquisition Adds Drug Delivery Technology

Feb. 24, 2006

By Jennifer Boggs

Global private equity firm Celtic Pharmaceutical Holdings LP gained access to a targeted drug delivery technology from IDEA AG, as well as clinical and preclinical products in pain and inflammation, dermatitis and psoriasis. (BioWorld Today)